RKLB Stock’s 24% Pullback: Risk or Buying Opportunity

There are pullbacks that indicate something is wrong, and there are pullbacks that indicate a stock is taking a breather after an unusual run. For Rocket Lab NASDAQ: RKLBthe nearly 24% drop from its 52-week high of $151 to Wednesday’s close of $115 looks more like the latter.

The stock is still up nearly 65% ​​on the year, business is operating at a record pace, and the broader space industry is approaching what could be one of its most important periods in history. But with multiple internal sales reported recently and a consensus analyst price of $97.19 below the current price, not all signs are pointing in the same direction. Here’s a closer look at what a pullback means and whether it represents a risk or an opportunity.

The Basic Story Hasn’t Changed

Regardless of what the short-term price action suggests, it’s worth making one thing clear: fundamental business momentum has not weakened. Q1 2026 brought in record revenue of $200.3 million, up 63.5% year over year.

Backlog reached a new record of $2.2 billion, up 20.2% quarter over quarter. Q2 guidance of $225 million to $240 million came in 12% above the previous analyst consensus, and the company signed more launches in Q1 alone than in all of 2025.

Aside from the earnings report, the recent news flow has been equally positive. The $90 million Space Force GEO satellite contract marked Rocket Lab’s first-ever contract role for a geostationary orbit mission. The acquisition of Motiv Space Systems closed, adding Mars-proven space robots and precision methods to the vertical integration stack. And the $3 billion equity distribution agreement, supported by 16 financial institutions, provides a major channel for financing Neutron’s development and future acquisitions without balance sheet constraints. Neutron itself remains on track for a first launch in Q4 2026, with five dedicated contracts already signed before it can deliver a single mission.

The SpaceX IPO Angle

One of the most interesting things in play right now is the SpaceX IPO timeline. SpaceX NASDAQ: SPCX filed its S-1 on May 20, aiming for a Nasdaq listing early on June 12 at a valuation between $1.75 trillion and $2 trillion. That event, if it goes ahead on time, could be a powerful catalyst for a broad rekindling of space industry stocks, and Rocket Lab in particular, as SpaceX’s closest publicly traded competitor.

On the other hand, however, bears may argue that, given the impressive performance of RKLB and other space names, taking profits across the industry may be a possibility before the event to fund the SpaceX purchase. Another potential case for the bears is that the SpaceX IPO could turn into a sell-out event for the industry in the short term, given the incredible excitement and participation leading up to the listing.

What Analysts and Institutions Say

The image of a commentator in RKLB needs a sincere frame. A consensus rating of moderate buy among 20 analysts indicates real long-term belief in the company’s trajectory. But the consensus price target of $97.19 sits about 21% below the current price, meaning the stock has significantly outperformed where most analysts legitimately have their models set.

That gap has been a consistent feature of RKLB’s performance in 2026, and analyst target reviews tend to follow the stock higher than lead it. Whether a new wave of upward revisions follows the Q2 earnings report in August remains to be seen.

On the institutional side, the institutional ownership base is consistently supported by significant revenue during the preceding 12 months.

It’s worth noting, however, that recent insider activity includes the sale of several shares by senior executives, a data point investors should be aware of, even if it doesn’t indicate a change in the long-term outlook. Selling inside at higher prices following a 100%+ YTD run is not unusual, but it is worth monitoring alongside the broader technical picture.

Pullback or Trouble?

The honest answer is that a 24% pullback from a 52-week high, in a stock that went over 100% in the weeks after the real catalysts, is more consistent with a general grind than a fundamental collapse. Business is ongoing. The backlog is growing. The Neutron program is developing. And the SpaceX IPO on June 12 could provide the next industry boost, bringing new attention and funding to the name. For long-term investors convinced of Rocket Lab’s thesis, the current setup looks more like an opportunity to focus more on key moving averages than a warning.

Before you consider Rocket Lab, you’ll want to hear this.

MarketBeat tracks Wall Street’s top and most effective research analysts and the stocks they recommend to their clients every day. MarketBeat identified five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Rocket Lab wasn’t on the list.

Although Rocket Lab currently has an Average Buy rating among analysts, top analysts believe these five stocks are the best.

View Five Stocks Here

MarketBeat analysts just released their top five short plays for June 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.

Get This Free Report

Do you like this article? Share with your colleagues.

The link is copied to the clipboard.